本页面由Tiger Trade Technology Pte. Ltd.提供服务

Fennec Pharmaceuticals Inc.

10.18
-0.5400-5.04%
盘后:10.180.00000.00%19:30 EDT
成交量:23.16万
成交额:236.04万
市值:3.57亿
市盈率:-84.83
高:10.75
开:10.72
低:10.09
收:10.72
52周最高:13.25
52周最低:5.65
股本:3,506.72万
流通股本:1,988.67万
量比:2.31
换手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-0.1200
每股收益(LYR):-0.3409
净资产收益率:-18.58%
总资产收益率:-1.16%
市净率:8.41
市盈率(LYR):-29.86

数据加载中...

2025/11/19

重要事件披露

Form 8-K - Current report
2025/11/17

重要事件披露

Form 8-K - Current report
2025/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/04

重要事件披露

Form 8-K - Current report
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/10

重要事件披露

Form 8-K - Current report
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities